Sharon Townson

Companies

• Monte Rosa TherapeuticsChief Technology Officer Jun 23, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MRMonte Rosa Therapeutics GLUE67,845 shares²$686.6K at $10.12Jul 6, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 6, 2026Sold 400 shares at $24.13 of Monte Rosa Therapeutics²
• Jul 6, 2026Sold 5,600 shares at $23.25 of Monte Rosa Therapeutics²
• Jul 6, 2026Exercised options 6,000 shares at $6.14 of Monte Rosa Therapeutics²
• Jun 23, 2026Sold 3,000 shares at $20.00 of Monte Rosa Therapeutics³
• Jun 23, 2026Exercised options 3,000 shares at $6.14 of Monte Rosa Therapeutics³
• Jun 17, 2026Sold 3,000 shares at $19.00 of Monte Rosa Therapeutics⁴
• Jun 17, 2026Exercised options 3,000 shares at $6.14 of Monte Rosa Therapeutics⁴
• May 29, 2026Sold 6,000 shares at $19.87 of Monte Rosa Therapeutics⁵
• May 29, 2026Exercised options 6,000 shares at $6.14 of Monte Rosa Therapeutics⁵
• Jan 5, 2026Sold 3,155 shares at $15.17 of Monte Rosa Therapeutics⁶
• Jan 2, 2026Granted 35,000 shares of Monte Rosa Therapeutics⁶
• Jan 2, 2025Granted 36,000 shares of Monte Rosa Therapeutics⁷